BioCorRx (OTC: BICX) Interview with CEO Brady Granier, discussing the company’s technology for treating opioid, alcohol and other addictions with Naltrexone implants. Brady discusses the company’s business model, progress towards FDA approval, and upcoming launch of a promising weight-loss program utilizing the Naltrexone implant.
Investor Presentation